Biogen Inc. buy Royal Bank of Canada
Start price
29.08.23
/
50%
€245.60
Target price
29.08.24
€329.05
Performance (%)
-24.84%
End price
30.08.24
€184.60
Summary
This prediction ended on 30.08.24 with a price of €184.60. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -24.84%. Royal_Bank_of_Canada has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 6.289% | 6.289% | -42.633% |
| iShares Core DAX® | -1.165% | -0.351% | 29.372% |
| iShares Nasdaq 100 | 1.585% | 4.605% | 15.331% |
| iShares Nikkei 225® | 1.992% | -2.018% | 3.699% |
| iShares S&P 500 | 2.158% | 4.638% | 10.756% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $354.00 to $357.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten